New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2014
07:46 EDTSRPTSarepta price target raised to $35 from $22 at RW Baird
Baird raised its price target on Sarepta following its update on pulmonary data that provides incremental evidence of efficacy of its 6MWT results from last month. The firm expects the next catalyst to be clarity on its pivotal trial design. Shares are Outperform rated.
News For SRPT From The Last 14 Days
Check below for free stories on SRPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 8, 2014
14:44 EDTSRPTInvestors await eteplirsen news from Sarepta amid speculation, TheStreet says
Subscribe for More Information
09:13 EDTSRPTSarepta April volatility increases to 166
Subscribe for More Information
April 7, 2014
11:11 EDTSRPTSarepta said to cancel appearance at Needham conference
Sarepta cancelled its appearance at Needham's conference tomorrow due to "other obligations," a re-tweet by The Street's Adam Feuerstein says, citing a confirmation from the company. Shares of Sarepta moved up 23c to $23.37 following circulation of the tweet.
April 3, 2014
12:32 EDTSRPTExpert thinks FDA could be swayed on eteplirsen by families, Boston Herald says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use